MoneyWorks4Me

The sales is pegged at Rs. 765.36 millions for the June 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 874.68 millions during the year-ago period.The Total Profit for the quarter ended June 2024 of Rs. 26.86 millions grew from Rs.-95.35 millions Operating profit Margin for the quarter ended June 2024 improved to 82.07% as compared to -34.54% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 765.36 874.68 -12.50 765.36 874.68 -12.50 3685.95 3722.53 -0.98
Other Income 0.20 0.20 0.00 0.20 0.20 0.00 0.98 4.36 -77.52
PBIDT 82.07 -34.54 -337.61 82.07 -34.54 -337.61 174.92 261.59 -33.13
Interest 37.48 34.12 9.85 37.48 34.12 9.85 139.17 129.56 7.42
PBDT 44.59 -68.66 -164.94 44.59 -68.66 -164.94 35.75 132.03 -72.92
Depreciation 38.73 34.19 13.28 38.73 34.19 13.28 146.32 109.89 33.15
PBT 5.86 -102.85 -105.70 5.86 -102.85 -105.70 -110.57 22.14 -599.41
TAX -21.00 -7.50 180.00 -21.00 -7.50 180.00 -20.08 9.44 -312.71
Deferred Tax -21.00 -7.50 180.00 -21.00 -7.50 180.00 -22.00 9.70 -326.80
PAT 26.86 -95.35 -128.17 26.86 -95.35 -128.17 -90.49 12.70 -812.52
Equity 158.28 158.28 0.00 158.28 158.28 0.00 158.28 158.28 0.00
PBIDTM(%) 10.72 -3.95 -371.55 10.72 -3.95 -371.55 4.75 7.03 -32.47

Mangalam Drugs&Org. Share Price

28.07 0.12 (0.43%)
18-Aug-2026 14:27 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1876.00
Dr. Reddys Labs. 1187.90
Cipla 1432.60
Lupin 2224.00
Zydus Lifesciences 1121.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: